Rapid Micro Biosystems

Article

Automated analysis in microbiology eliminates error-prone manual steps and saves labor; rapidly detecting contamination enables manufacturers to reduce inventory carrying costs, shorten manufacturing cycle time, and reduce product losses...Read more:

Automated analysis in microbiology eliminates error-prone manual steps and saves labor; rapidly detecting contamination enables manufacturers to reduce inventory carrying costs, shorten manufacturing cycle time, and reduce product losses, delivering significant cost savings and increased operational efficiency. The Growth Direct™ System detects contamination earlier, delivering compelling economic benefits to manufacturers, while improving their quality process. The Growth Direct System is an automated rapid enumeration and reporting system for microbial quality control environmental monitoring, sterility and bioburden testing.

The Growth Direct System uses proprietary digital imaging technology that automatically enumerates microcolonies days earlier than the traditional visual plate counting methods. The system captures the native fluorescence (autofluorescence) that is emitted by all living cells. By detecting microcolonies composed of a small number of cells, the Growth Direct test can start to detection microbial growth in a matter of hours with final results in half the time of the traditional, visual methods. Because the test is non-destructive, colonies are available for identification without the need for a re-culture step.

Rapid Micro Biosystems regularly hosts hands-on workshops showcasing the Growth Direct™ System. Visit www.rapidmicrobio.com/workshops for more details.

Contact Details:
www.rapidmicrobio.cominfo@rapidmicrobio.com

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content